However, celecoxib had a marginally significant effect on reducing metachronous recurrences compared with placebo [ 68 ].
← all excerpts
Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer.
1
—
—
However, celecoxib had a marginally significant effect on reducing metachronous recurrences compared with placebo [ 68 ].